Trials / Completed
CompletedNCT02394379
Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL
A Prospective, Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber Intraocular Lens (IOL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.
Detailed description
The objective of this post approval safety study is to evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery at up to three years post implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Trulign™ Toric IOL | Trulign™ Toric Posterior Chamber IOL is a modified plate haptic lens |
Timeline
- Start date
- 2015-03-19
- Primary completion
- 2019-08-05
- Completion
- 2019-08-05
- First posted
- 2015-03-20
- Last updated
- 2019-11-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02394379. Inclusion in this directory is not an endorsement.